Patient Portal

Julie A. Margenthaler, MD, FACS

Professor, Surgery
Division of General Surgery
Section of Surgical Oncology

Specialty Areas

Breast Surgery
Breast Health
Breast Oncology

Board Certifications

General Surgery

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

breast cancer, breast cancer in young women less than 40 years old, breast reconstruction liaison, sentinel lymph node biopsy.

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine
Breast Health Center

4921 Parkview Place
St. Louis, MO 63110

Suite: F
Floor: 5
Office Phone: 314-362-2280
Fax: 888-352-8360

Education

Education

Fellowship: Breast Disease , Washington University School of Medicine, St. Louis MO 2006
Residency: General Surgery, (PGY-3-5), Washington University School of Medicine 2005
Fellowship: Research, Washington University School of Medicine, St. Louis MO 2002
Residency: General Surgery Residency (PGY-1, 2): Saint Louis University Hospitals 1999
Medical Degree: Southern Illinois University School of Medicine 1997

Publication & Research

Publication & Research

Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change.
Hwang ES, Balch CM, Balch GC, Feldman SM, Golshan M, Grobmyer SR, Libutti SK, Margenthaler JA, Sasidhar M, Turaga KK, Wong SL, McMasters KM, Tanabe KK
Ann Surg Oncol. 2020 Aug; 27(8)2600-2613. doi: 10.1245/s10434-020-08673-6.

PMID:
    32535870
    [PubMed - indexed for MEDLINE]
Related citations


A prospective cohort study to analyze the interaction of tumor-to-breast volume in breast conservation therapy versus mastectomy with reconstruction.
Dolen U, Thornton M, Tenenbaum MM, Aripoli A, Patel A, Cyr AE, Yan Y, Appleton CM, Margenthaler JA, Myckatyn TM
Breast Cancer Res Treat. 2020 Jun; 181(3)611-621. doi: 10.1007/s10549-020-05639-w.

PMID:
    32350679
    [PubMed - in process]
Related citations


Repurposing Molecular Imaging and Sensing for Cancer Image-Guided Surgery.
Mondal SB, O'Brien CM, Bishop K, Fields RC, Margenthaler JA, Achilefu S
J Nucl Med. 2020 Aug; 61(8)1113-1122. doi: 10.2967/jnumed.118.220426.

PMID:
    32303598
    [PubMed - in process]
Related citations


Robotic Mastectomy-Program Malfunction?
Margenthaler JA
JAMA Surg. 2020 Apr 1; doi: 10.1001/jamasurg.2019.6361.

PMID:
    32236516
    [PubMed - as supplied by publisher]
Related citations


Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy.
Kennedy WR, Tricarico C, Gabani P, Weiner AA, Altman MB, Ochoa LL, Thomas MA, Margenthaler JA, Sanati S, Peterson LL, Ma CX, Ademuyiwa FO, Zoberi I
J Natl Compr Canc Netw. 2020 Mar; 18(3)288-296. doi: 10.6004/jnccn.2019.7366.

PMID:
    32135512
    [PubMed - in process]
Related citations


Single-Institution Phase 1/2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial-Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer.
Kennedy WR, Thomas MA, Stanley JA, Luo J, Ochoa LL, Clifton KK, Cyr AE, Margenthaler JA, DeWees TA, Price A, Kashani R, Green O, Zoberi I
Int J Radiat Oncol Biol Phys. 2020 Jun 1; 107(2)344-352. doi: 10.1016/j.ijrobp.2020.02.021.

PMID:
    32084524
    [PubMed - in process]
Related citations


A tale of two operations: re-excision as a quality measure.
Elmore LC, Margenthaler JA
Gland Surg. 2019 Dec; 8(6)593-595. doi: 10.21037/gs.2019.11.24.

PMID:
    32042664
    [PubMed]
Related citations


Oncologic Safety and Outcomes in Patients Undergoing Nipple-Sparing Mastectomy.
Margenthaler JA, Gan C, Yan Y, Cyr AE, Tenenbaum M, Hook D, Myckatyn TM
J Am Coll Surg. 2020 Apr; 230(4)535-541. doi: 10.1016/j.jamcollsurg.2019.12.028.

PMID:
    32032724
    [PubMed - in process]
Related citations


The Landmark Series: Axillary Management in Breast Cancer.
Fisher CS, Margenthaler JA, Hunt KK, Schwartz T
Ann Surg Oncol. 2020 Mar; 27(3)724-729. doi: 10.1245/s10434-019-08154-5.

PMID:
    31863417
    [PubMed - in process]
Related citations


Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.
Gabani P, Patel H, Thomas MA, Bottani B, Goddu SM, Straube W, Margenthaler JA, Ochoa L, Bradley JD, Zoberi I
Clin Transl Radiat Oncol. 2019 Nov; 19116-122. doi: 10.1016/j.ctro.2019.09.005.

PMID:
    31692702
    [PubMed]
Related citations


Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation.
Kennedy WR, Roach MC, Thomas MA, Ochoa L, Altman MB, Hernandez-Aya LF, Cyr AE, Margenthaler JA, Zoberi I
Pract Radiat Oncol. 2020 May - Jun; 10(3)e128-e135. doi: 10.1016/j.prro.2019.09.007.

PMID:
    31541717
    [PubMed - in process]
Related citations


Predictors of Locoregional Recurrence After Failure to Achieve Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Gabani P, Merfeld E, Srivastava AJ, Weiner AA, Ochoa LL, Mullen D, Thomas MA, Margenthaler JA, Cyr AE, Peterson LL, Naughton MJ, Ma C, Zoberi I
J Natl Compr Canc Netw. 2019 Apr 1; 17(4)348-356. doi: 10.6004/jnccn.2018.7103.

PMID:
    30959467
    [PubMed - indexed for MEDLINE]
Related citations


Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
Gabani P, Weiner AA, Hernandez-Aya LF, Khwaja S, Roach MC, Ochoa LL, Mullen D, Thomas MA, Matesa MA, Margenthaler JA, Cyr AE, Naughton MJ, Ma C, Sanati S, Zoberi I
Breast J. 2019 May; 25(3)363-372. doi: 10.1111/tbj.13230.

PMID:
    30920124
    [PubMed - indexed for MEDLINE]
Related citations


Value-Based Analysis for Breast Cancer Treatment: We Don't Know What We Don't Know.
Schwartz TL, Margenthaler JA
Ann Surg Oncol. 2019 May; 26(5)1167-1169. doi: 10.1245/s10434-019-07170-9.

PMID:
    30675697
    [PubMed - indexed for MEDLINE]
Related citations


Nipple-Sparing Mastectomy Incisions for Cancer Extirpation Prospective Cohort Trial: Perfusion, Complications, and Patient Outcomes.
Odom EB, Parikh RP, Um G, Kantola SW, Cyr AE, Margenthaler JA, Tenenbaum MM, Myckatyn TM
Plast Reconstr Surg. 2018 Jul; 142(1)13-26. doi: 10.1097/PRS.0000000000004498.

PMID:
    29878989
    [PubMed - indexed for MEDLINE]
Related citations


Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls.
Ekenga CC, Pérez M, Margenthaler JA, Jeffe DB
Cancer. 2018 May 1; 124(9)2026-2035. doi: 10.1002/cncr.31270.

PMID:
    29437204
    [PubMed - indexed for MEDLINE]
Related citations


Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
Gabani P, Cyr AE, Zoberi JE, Ochoa LL, Matesa MA, Thomas MA, Garcia J, Margenthaler JA, Naughton MJ, Ma C, Sanati S, Zoberi I
Brachytherapy. 2018 Jan - Feb; 17(1)171-180. doi: 10.1016/j.brachy.2017.09.009.

PMID:
    29089275
    [PubMed - indexed for MEDLINE]
Related citations


Communication as the Key to Breast Conservation.
Margenthaler JA, Cyr AE
JAMA Surg. 2018 Jan 1; 153(1)36. doi: 10.1001/jamasurg.2017.3435.

PMID:
    28903159
    [PubMed - indexed for MEDLINE]
Related citations


Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction Procedures.
Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Wallace AE, Fraser VJ
JAMA Surg. 2017 Sep 20; 152(9)e172338. doi: 10.1001/jamasurg.2017.2338.

PMID:
    28724125
    [PubMed - indexed for MEDLINE]
Related citations


Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution.
Dull B, Linkugel A, Margenthaler JA, Cyr AE
J Natl Compr Canc Netw. 2017 Jun; 15(6)783-789. doi: 10.6004/jnccn.2017.0104.

PMID:
    28596258
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2019:

Company Name: Genetech

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2020